U.S. markets closed

NeuroBo Pharmaceuticals, Inc. (NRBO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
6.35-0.08 (-1.24%)
At close: 4:00PM EDT
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Annual
Quarterly
Premium required to access monthly data
Monthly
Subscribe to Premium to download historical data
 
As of Date: 8/10/2020
Current
3/31/202012/31/20199/30/20196/30/2019
Market Cap (intraday) 5
108.91M217.91M5.21M5.68M11.55M
Enterprise Value 3
99.23M204.12M3.35M2.05M6.09M
Trailing P/E
N/AN/AN/AN/AN/A
Forward P/E 1
N/AN/AN/AN/AN/A
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/A
Price/Sales (ttm)
N/AN/AN/AN/AN/A
Price/Book (mrq)
14.0717.73N/A2.892.60
Enterprise Value/Revenue 3
N/AN/AN/AN/AN/A
Enterprise Value/EBITDA 6
-4.42-43.13-0.26-0.89-2.59

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-59.69%
S&P500 52-Week Change 317.36%
52 Week High 330.00
52 Week Low 35.95
50-Day Moving Average 37.65
200-Day Moving Average 312.34

Share Statistics

Avg Vol (3 month) 371.57k
Avg Vol (10 day) 349.83k
Shares Outstanding 516.43M
Float 2.46M
% Held by Insiders 12.68%
% Held by Institutions 12.27%
Shares Short (Jul 30, 2020) 4202.54k
Short Ratio (Jul 30, 2020) 42.08
Short % of Float (Jul 30, 2020) 44.49%
Short % of Shares Outstanding (Jul 30, 2020) 41.23%
Shares Short (prior month Jun 29, 2020) 4200.81k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:25
Last Split Date 3Dec 30, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Jun 29, 2020

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-33.64%
Return on Equity (ttm)-134.58%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -10.79M
Net Income Avi to Common (ttm)-24.06M
Diluted EPS (ttm)N/A
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)14.3M
Total Cash Per Share (mrq)0.88
Total Debt (mrq)105k
Total Debt/Equity (mrq)0.85
Current Ratio (mrq)4.87
Book Value Per Share (mrq)N/A

Cash Flow Statement

Operating Cash Flow (ttm)-11.09M
Levered Free Cash Flow (ttm)-5.72M